BEA TECHNOLOGIES S.p.A.

Filter elements with high capacity nanofibers for the purification of biological - pharmaceutical products. 

BEA Technologies, an Italian company with a strong international presence, is among the leaders in Europe in the production of filters with nanofibers. In the field of supply in the pharmaceutical sector, BEA Technologies offers customized and innovative solutions for the filtration of "critical" products.

BEA Technologies offers three series of high-performance filter elements with nanofibers called MAGNEX, NANOTRAK and NOVATRAK, that meet the needs of companies engaged in the production of new generation drugs (which have a high degree of sensitivity during the production process). The development of these filter elements has started from the testing of available filter media made of nanofibers until selecting the media with the best performance and incorporating them in the design of new filter elements. The filter elements based on nanofiber filter media have been tested with different solutions and products to confirm filtration results and compliance with the high level of quality requirements for biological applications in the pharmaceutical industry.

Extending the “service life” of the filter elements is one of the main targets pursued in the company’s research. The “goal” is to ensure optimal operation in demanding use situations and for the purification of "critical" or viscous products.

Critical microfiltration products are produced in a controlled atmosphere environment (clean room) and in compliance with the GMP guidelines, to ensure a high level of quality and cleanliness for biological applications.

Discover more on www.bea-italy.com

Bea Technologies Spa

Phone +39 02 339 271  |  Fax +39 02 339 0713  |  info@bea-italy.com  |  www.bea-italy.com

Phone +39 02 339 271  |  Fax +39 02 339 0713
info@bea-italy.com  |  www.bea-italy.com

02/24/2024 06:49:12
  • Home | Unpacking innovation in biologics 
  • In this issue
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Verder Company Insight
  • Verder
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Controlant Company Insight
  • Controlant
  • Datwyler
  • Baxter
  • Comment
  • Novel therapies will drive Cushing’s syndrome market growth
  • Interim analysis backs Keytruda use in first-line cervical cancer therapy
  • Unmet needs and opportunities for axillary hyperhidrosis
  • Pfeiffer Vacuum
  • HOF Sonderanlagenbau
  • Avery Dennison Company Insight
  • Avery Dennison
  • In Depth
  • The reality of optimising real-world data
  • The ethics of vaccine boosters
  • Forever young: can science cure ageing?
  • Predicting the placebo response
  • US regulators struggle to keep up with a global market
  • BCG: the history and modern-day uses of the tuberculosis vaccine
  • BEA Technologies
  • Myonex
  • Contract Pharmaceuticals Limited Canada
  • Single Use Support
  • Skyepharma
  • In Data
  • Cloud hiring efforts
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
10/21/2021 00:00:00